Found 20 matching trials
TACTIC - TAA Specific Cytotoxic T Lymphocytes in Patients With Breast Cancer PHASE2 Status - CLOSED TO PATIENT ENROLLMENT (CNPE)
The study is being conducted ...
Show More Location
Houston Methodist Hospital
Learn More & Join Trial
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies PHASE1 This Phase I dose-escalation trial is designed to evaluate the safety of ad...
Show More Location
Childrens National Medical Center
Learn More & Join Trial
Study of Mana 312 (Multi Tumor-Associated Antigen T Cells) in Adults With AML/MDS After HSCT PHASE1 This is a Phase 1, open-label, non-randomized, single and multiple dose esc...
Show More Location
Colorado Blood Cancer Institute
Learn More & Join Trial
Safety and Efficacy of Allogeneic MSCs in Promoting T-regulatory Cells in Patients With Small Abdominal Aortic Aneurysms PHASE1 This project is to determine the safety and explore the effectiveness of al...
Show More Location
Richard L. Roudebush VA Medical Center, Indianapolis, IN
Learn More & Join Trial
Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma PHASE1 This is a Phase I, open-label multi-site trial designed to evaluate the saf...
Show More Status
Active Not Recruiting
Location
Utah University School of Medicine/Huntsman Cancer Institute
Learn More & Join Trial
Phase 1 Study Of Intrathecal Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells For Patients With Leptomeningeal Melanoma PHASE1 The proposed study is a single arm Phase I trial aimed at treating up to 6 ...
Show More Location
The University of Texas M. D. Anderson Cancer Center
Learn More & Join Trial
(Bispecific) Antibodies in Cancer Patients N/A The aim of this project is to provide (bispecific) antibodies to individual...
Show More Location
University Hospital Tuebingen
Learn More & Join Trial
Research Study Utilizing Expanded Multi-antigen Specific Lymphocytes for the Treatment of Solid Tumors PHASE1 Patients with high-risk solid tumors, those that are refractory to standard...
Show More Status
Active Not Recruiting
Location
Children's National Medical Center
Learn More & Join Trial
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma PHASE1 This study is for patients that have a cancer called Multiple Myeloma, mono...
Show More Status
Active Not Recruiting
Location
Harris Health Ben Taub Hospital
Learn More & Join Trial
TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic Cancer PHASE1 Status - CLOSED TO PATIENT ENROLLMENT (CNPE)
Patients who have pancreatic ...
Show More Learn More & Join Trial